Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases

Overview of attention for article published in Genetics in Medicine, October 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 15 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 74 Dimensions

Readers on

mendeley: 158 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 18 X posts from 15 X users, with an upper bound of 48,097 followers.

[2] Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases | https://t.co/ZN0l4j3voC #healtheconomics [3/4]

10 Feb 2021

Reply Repost Favourite

RT @Ted_LQ4L: Genetic Testing does more than assess #medicine compatibility. It also is used for #heartdisease diagnosis. This review finds…

25 Feb 2020

Reply Repost Favourite

Genetic Testing does more than assess #medicine compatibility. It also is used for #heartdisease diagnosis. This review finds overwhelming evidence of the cost-effectiveness of Pharmacogenomic prescribing for clopidogrel & warfarin. #Cardiology #Doctor

24 Feb 2020

Reply Repost Favourite

This review finds Pharmacogenomic guided prescribing yields overwhelming evidence of cost-effectiveness for CVD management, & holds enormous potential for reducing the chances of drug-related adverse events. https://t.co/Ubla7Et84v #cardiology #Doctor

11 Feb 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 14 additional X posts.